CCM
HALO icon

Cloud Capital Management’s Halozyme HALO Stock Holding History

Cloud Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19
Closed -$1K – 697
2025
Q3 		$1K Buy
+19
New +$1.26K ﹤0.01% 834

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cloud Capital Management's HALO Position: Q4 2025 in Review

Cloud Capital Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 19 shares — an estimated $1K sold.

Cloud Capital Management first reported a position in HALO in Q3 2025 and held it in 1 quarter. The position peaked at $1K in Q3 2025. 619 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Cloud Capital Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Cloud Capital Management sold 19 Halozyme shares in Q4 2025, an estimated $1K.
  • Cloud Capital Management first reported a position in Halozyme in Q3 2025 and held it in 1 quarter.
  • Cloud Capital Management's Halozyme position peaked at $1K in Q3 2025.
  • 619 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.